Crossmark

Longitudinal monitoring of urinary C-peptide levels following discontinuation of sacubitril/valsartan in a type 2 diabetes patient: a case report and literature review

Crossref DOI link: https://doi.org/10.1007/s13340-025-00816-y

Published Online: 2025-03-31

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kondo, Keiichiro

Minamino, Hiroto

Murakami, Takaaki https://orcid.org/0000-0003-3844-1138
Okamura, Emi

Hakata, Takuro

Ueda, Yohei

Taura, Daisuke

Yabe, Daisuke
License Information

Text and Data Mining valid from 2025-03-31

Version of Record valid from 2025-03-31
More Information

Article History

Received: 23 January 2025

Accepted: 19 March 2025

First Online: 31 March 2025

Declarations

:

: The authors have no potential conflicts of interest to disclose.

: In publishing this study, written consent was obtained from all patients and patients’ legal representatives involved in the study.

Document is current

Any future updates will be listed below